Nevro Corp. (NVRO)

Market Cap	153.82M
Revenue (ttm)	419.15M
Net Income (ttm)	-69.31M
Shares Out	37.47M
EPS (ttm)	-1.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	207,564
Open	4.200
Previous Close	4.270
Day's Range	4.060 - 4.260
52-Week Range	3.950 - 22.640
Beta	0.83
Analysts	Hold
Price Target	8.50 (+107.07%)
Earnings Date	Nov 11, 2024

About NVRO

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implant...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 6, 2014
• Employees: 1,215
• Stock Exchange: NYSE
• Ticker Symbol: NVRO
• Website: https://nevro.com

Analyst Forecast

According to 14 analysts, the average rating for NVRO stock is "Hold." The 12-month stock price forecast is $8.5, which is an increase of 107.07% from the latest price.

Price Target

$8.5

(107.07% upside)

Analyst Consensus: Hold